# Improving Medication Safety for Kidney Disease With a Digital Drug Dosing Tool in Nova Scotia Community Pharmacy Practice.

> **NCT06820372** · — · NOT_YET_RECRUITING · sponsor: **Nova Scotia Health Authority** · enrollment: 125 (estimated)

## Conditions studied

- Chronic Kidney Disease Stage 4
- Chronic Kidney Disease Stage 5

## Interventions

- **OTHER:** Electronic Drug Dosing and Decision Support Kidney (eDoseCKD) Tool

## Key facts

- **NCT ID:** NCT06820372
- **Lead sponsor:** Nova Scotia Health Authority
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-06-01
- **Primary completion:** 2026-03-31
- **Final completion:** 2026-05-01
- **Target enrollment:** 125 (ESTIMATED)
- **Last updated:** 2025-02-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06820372

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06820372, "Improving Medication Safety for Kidney Disease With a Digital Drug Dosing Tool in Nova Scotia Community Pharmacy Practice.". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06820372. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*